Nationwide Evaluation of New Psychiatric Drugs is Urgent Need
In this testimony before the House Appropriations Subcommittee on Labor, Gorman explains to the budget committee that several
new tranquilizing drugs (reserpine and chlorpromazine) might revolutionize psychiatry and alleviate overcrowding in mental
hospitals. However, no controlled studies had been done to assess the drugs' physiological effects, or their suitability
for various psychiatric disorders. Only the National Institute of Mental Health was equipped to do such a large-scale evaluation,
and only Congress could authorize the funding for it.
Number of Image Pages:
13 (973,453 Bytes)
1956-02-16 (February 16, 1956)
This item is in the public domain. It may be used without permission.
Medical Subject Headings (MeSH):
A Full-time Activist: The National Committee Against Mental Illness, 1953-1963
The First Year's Experience with Large-Scale Use of Chlorpromazine and Reserpine in the Mental Hygiene Institutions of
New York State: A Preliminary Report (February 16, 1956)
A Proposal for the Technical Evaluation of Psychiatric Drugs (February 16, 1956)